Injectable Drug Delivery Devices Market Report

Injectable Drug Delivery Devices Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Mar 28, 2020
  • PAGES：180
  • REPORT CODE：GMM524184
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Injectable Drug Delivery Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.5% during the forecast period.

    This report presents the market size and development trends by detailing the Injectable Drug Delivery Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Injectable Drug Delivery Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Injectable Drug Delivery Devices industry and will help you to build a panoramic view of the industrial development.

    Injectable Drug Delivery Devices Market, By Type:

    • Conventional Drug Delivery Devices

    • Novel Drug Delivery Devices

    Injectable Drug Delivery Devices Market, By Application:

    • Hospitals

    • Clinics

    • Others

    Some of the leading players are as follows:

    • Medicago

    • Endocyte

    • Genentech

    • UCB Group (UCB)

    • Boehringer Ingelheim

    • Crossject Medical Technology

    • Zogenix

    • BIND Biosciences

    • Bend Research

    • Pulmatrix

    • Apogee Technology

    • MicroCHIPS

    • Liquidia Technologies

    • Impax Laboratories

    • QLT

    • Polymer Factory

    • Presage Bioscience

    • Pearl Therapeutics

    • Alkermes

    • Piedmont Pharmaceuticals

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Injectable Drug Delivery Devices Market: Technology Type Analysis

    • 4.1 Injectable Drug Delivery Devices Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Injectable Drug Delivery Devices Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Conventional Drug Delivery Devices

      • 4.3.2 Novel Drug Delivery Devices

    5 Injectable Drug Delivery Devices Market: Product Analysis

    • 5.1 Injectable Drug Delivery Devices Product Market Share Analysis, 2018 & 2026

    • 5.2 Injectable Drug Delivery Devices Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Injectable Drug Delivery Devices Market: Application Analysis

    • 6.1 Injectable Drug Delivery Devices Application Market Share Analysis, 2018 & 2026

    • 6.2 Injectable Drug Delivery Devices Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospitals

      • 6.3.2 Clinics

      • 6.3.3 Others

    7 Injectable Drug Delivery Devices Market: Regional Analysis

    • 7.1 Injectable Drug Delivery Devices Regional Market Share Analysis, 2018 & 2026

    • 7.2 Injectable Drug Delivery Devices Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Medicago

      • 9.1.1 Medicago Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Endocyte

      • 9.2.1 Endocyte Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Genentech

      • 9.3.1 Genentech Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 UCB Group (UCB)

      • 9.4.1 UCB Group (UCB) Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Boehringer Ingelheim

      • 9.5.1 Boehringer Ingelheim Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Crossject Medical Technology

      • 9.6.1 Crossject Medical Technology Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Zogenix

      • 9.7.1 Zogenix Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 BIND Biosciences

      • 9.8.1 BIND Biosciences Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Bend Research

      • 9.9.1 Bend Research Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Pulmatrix

      • 9.10.1 Pulmatrix Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Apogee Technology

      • 9.11.1 Apogee Technology Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 MicroCHIPS

      • 9.12.1 MicroCHIPS Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Liquidia Technologies

      • 9.13.1 Liquidia Technologies Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Impax Laboratories

      • 9.14.1 Impax Laboratories Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 QLT

      • 9.15.1 QLT Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Polymer Factory

      • 9.16.1 Polymer Factory Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

    • 9.17 Presage Bioscience

      • 9.17.1 Presage Bioscience Company overview

      • 9.17.2 Financial performance

      • 9.17.3 Product benchmarking

      • 9.17.4 Strategic initiatives

      • 9.17.5 SWOT analysis

    • 9.18 Pearl Therapeutics

      • 9.18.1 Pearl Therapeutics Company overview

      • 9.18.2 Financial performance

      • 9.18.3 Product benchmarking

      • 9.18.4 Strategic initiatives

      • 9.18.5 SWOT analysis

    • 9.19 Alkermes

      • 9.19.1 Alkermes Company overview

      • 9.19.2 Financial performance

      • 9.19.3 Product benchmarking

      • 9.19.4 Strategic initiatives

      • 9.19.5 SWOT analysis

    • 9.20 Piedmont Pharmaceuticals

      • 9.20.1 Piedmont Pharmaceuticals Company overview

      • 9.20.2 Financial performance

      • 9.20.3 Product benchmarking

      • 9.20.4 Strategic initiatives

      • 9.20.5 SWOT analysis

     

    The List of Tables and Figures (Totals 97 Figures and 151 Tables)

    • Figure Conventional Drug Delivery Devices Injectable Drug Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Novel Drug Delivery Devices Injectable Drug Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Hospitals market, 2015 - 2026 (USD Million)

    • Figure Clinics market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Injectable Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table North America Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table North America Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table North America Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Canada Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Canada Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Europe Injectable Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table Europe Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Europe Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Europe Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Germany Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Germany Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table France Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table France Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Italy Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Italy Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Spain Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Spain Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Injectable Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table China Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table China Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Japan Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Japan Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table India Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table India Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Injectable Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table MEA Injectable Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table MEA Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table MEA Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table MEA Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Injectable Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Injectable Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Injectable Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Medicago Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Endocyte Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Genentech Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table UCB Group (UCB) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Crossject Medical Technology Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Zogenix Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BIND Biosciences Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bend Research Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pulmatrix Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Apogee Technology Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table MicroCHIPS Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Liquidia Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Impax Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table QLT Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Polymer Factory Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Presage Bioscience Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pearl Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Alkermes Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Piedmont Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US